Latest Healthcare Policy news from across the web.
Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."
Read full article →Some jurisdictions have weakened their public health authorities in response to criticism of lockdowns, school closures, mask mandates, vaccine requirements and other COVID-era restrictions.
Read full article →Otsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.
Read full article →The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.
Read full article →For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…
Read full article →Assessing the health secretary's biggest challenges, and a look at new rules that inject politics into the NIH.
Read full article →Inceptive Nucleics and Alnylam's partnership, why Grail's "failed" trial still matters, and other biotech news from The Readout
Read full article →In this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.
Read full article →Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law
Read full article →An Ebola update, Trump to strip job protections of NIH officials, and more health news from Morning Rounds
Read full article →Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
Read full article →There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo. Trials are going on for several candidates. How long will it take?
Read full article →